Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How useful is fecal calprotectin for the diagnosis of IBD and colorectal cancer?

Nature Clinical Practice Gastroenterology & Hepatology volume 5, pages 16–17 (2008)Cite this article

boxed-textvon Roon AC et al. (2007) Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 102: 803–813

Fecal calprotectin has a role in distinguishing inflammatory from non-inflammatory conditions in patients with IBD with symptom exacerbation; however, fecal calprotectin is not a useful screening test for colorectal cancer

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lashner BA (2006) Sensitivity-specificity trade-off for capsule endoscopy in IBD: is it worth it? Am J Gastroenterol 101: 965–966

    Article  Google Scholar 

  2. Cole P and Morrison AS (1980) Basic issues in population screening for cancer. J Natl Cancer Inst 64: 1263–1272

    CAS  PubMed  Google Scholar 

  3. Kronborg O and Regula J (2007) Population screening for colorectal cancer: advantages and drawbacks. Dig Dis 25: 270–273

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Cleveland Clinic/A30, 9500 Euclid Ave, Cleveland, OH 44195, USA lashneb@ccf.org

Authors and Affiliations

  1. BA Lashner is Professor of Medicine at the Cleveland Clinic, Cleveland, OH, USA.,

    Bret A Lashner

Authors
  1. Bret A Lashner
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lashner, B. How useful is fecal calprotectin for the diagnosis of IBD and colorectal cancer?. Nat Rev Gastroenterol Hepatol 5, 16–17 (2008). https://doi.org/10.1038/ncpgasthep1003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep1003

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing